Yoshiya Tanaka Selected Research

Myelodysplastic-Myeloproliferative Diseases

1/2022

Allogeneic stem cell transplantation for trisomy 8-positive myelodysplastic syndrome or myelodysplastic/myeloproliferative disease with refractory Behçet's disease: Case report and the review of literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshiya Tanaka Research Topics

Disease

277	Rheumatoid Arthritis 11/2022 - 07/2001
66	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2022 - 10/2003
45	Type 2 Diabetes Mellitus (MODY) 04/2022 - 06/2005
41	Infections 07/2022 - 02/2004
36	Osteoporosis 04/2022 - 06/2003
33	Neoplasms (Cancer) 04/2022 - 01/2002
32	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 02/2002
26	Inflammation (Inflammations) 05/2022 - 07/2001
22	Herpes Zoster 07/2022 - 01/2016
19	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 02/2006
16	Immunoglobulin G4-Related Disease 01/2022 - 02/2012
15	Pathologic Processes 01/2022 - 03/2002
14	Arthritis (Polyarthritis) 10/2022 - 02/2004
14	Necrosis 05/2022 - 08/2012
14	Rheumatic Diseases (Rheumatism) 09/2020 - 01/2007
13	Bone Resorption 04/2022 - 08/2002
12	Hyperglycemia 01/2020 - 06/2005
11	Psoriatic Arthritis 07/2022 - 07/2016
10	Pain (Aches) 07/2022 - 03/2013
9	Bone Fractures (Bone Fracture) 11/2019 - 06/2003
8	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 07/2015
8	Hypercalcemia (Milk Alkali Syndrome) 10/2020 - 01/2004
7	Dermatomyositis (Dermatopolymyositis) 11/2022 - 01/2008
7	Fibrosis (Cirrhosis) 01/2022 - 10/2009
7	Drug-Related Side Effects and Adverse Reactions 05/2020 - 01/2007
7	Vascular Calcification 01/2019 - 08/2006
7	Diabetes Mellitus 01/2017 - 06/2006
7	Atherosclerosis 05/2016 - 05/2003
6	Lupus Nephritis 10/2022 - 01/2016
6	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2004
6	Vasculitis (Vasculitides) 01/2022 - 12/2003
6	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2020 - 06/2002
6	Insulin Resistance 01/2019 - 01/2006
6	Graves Disease (Basedow Disease) 01/2017 - 01/2014
5	Fatigue 07/2022 - 11/2017
5	Hypertension (High Blood Pressure) 01/2022 - 07/2012
5	Lung Diseases (Lung Disease) 01/2022 - 11/2012
5	Fever (Fevers) 01/2022 - 11/2005

Drug/Important Bio-Agent (IBA)

68	Methotrexate (Mexate)FDA LinkGeneric 11/2022 - 12/2002
50	Biological ProductsIBA 04/2022 - 09/2005
42	GlucocorticoidsIBA 04/2022 - 06/2003
41	Antirheumatic Agents (DMARD)IBA 01/2022 - 02/2004
39	Janus Kinase InhibitorsIBA 07/2022 - 01/2012
37	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2006
31	Adalimumab (Humira)FDA Link 02/2022 - 06/2012
30	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2022 - 06/2005
29	CytokinesIBA 01/2022 - 07/2001
26	baricitinibIBA 05/2022 - 03/2016
26	tofacitinibIBA 06/2021 - 08/2011
25	tocilizumab (atlizumab)FDA Link 01/2021 - 04/2011
23	Monoclonal AntibodiesIBA 03/2022 - 01/2008
22	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2005
19	Diphosphonates (Bisphosphonates)IBA 05/2021 - 11/2002
18	Etanercept (Enbrel)FDA Link 03/2020 - 01/2009
17	Abatacept (Orencia)FDA Link 04/2022 - 01/2014
17	Immunoglobulin G (IgG)IBA 03/2022 - 02/2012
17	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 07/2011
17	AutoantibodiesIBA 12/2021 - 12/2002
17	Pharmaceutical PreparationsIBA 03/2021 - 06/2005
16	Interleukin-6 (Interleukin 6)IBA 05/2022 - 11/2007
16	Infliximab (Remicade)FDA Link 11/2021 - 01/2007
14	peficitinibIBA 07/2022 - 06/2016
14	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2009
14	Janus KinasesIBA 05/2022 - 01/2014
13	Rituximab (Mabthera)FDA Link 02/2022 - 01/2007
13	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2013
12	Prednisolone (Predate)FDA LinkGeneric 10/2022 - 02/2004
12	Insulin (Novolin)FDA Link 04/2022 - 06/2005
12	Denosumab FDA Link 11/2021 - 05/2010
11	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 10/2003
11	Certolizumab Pegol FDA Link 01/2021 - 07/2014
11	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2018 - 12/2004
10	AntibodiesIBA 11/2022 - 06/2011
9	SteroidsIBA 10/2022 - 10/2003
9	Hemoglobins (Hemoglobin)IBA 04/2022 - 03/2005
9	upadacitinibIBA 02/2022 - 01/2019
8	DNA (Deoxyribonucleic Acid)IBA 05/2022 - 10/2003
8	belimumabIBA 01/2022 - 01/2018
7	GLPG0634IBA 04/2022 - 01/2021
7	InterleukinsIBA 03/2022 - 12/2014
7	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 12/2012
7	InterferonsIBA 01/2022 - 06/2012
7	AntigensIBA 01/2021 - 08/2002
7	Proteins (Proteins, Gene)FDA Link 12/2020 - 06/2005
7	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 12/2020 - 04/2013
6	sarilumabIBA 07/2022 - 09/2014
6	LigandsIBA 05/2022 - 04/2013
6	anifrolumabIBA 02/2022 - 01/2020
6	Vitamin D FDA LinkGeneric 02/2022 - 12/2012
6	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 01/2020
6	sirukumabIBA 01/2021 - 09/2014
6	alfacalcidolIBA 07/2020 - 01/2004
6	golimumab FDA Link 09/2018 - 06/2012
6	oxidized low density lipoproteinIBA 03/2018 - 02/2002
5	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 01/2018
5	CreatinineIBA 04/2021 - 09/2002

Therapy/Procedure

146	Therapeutics 11/2022 - 09/2002
8	Glycemic Control 02/2019 - 06/2006
7	Remission Induction 01/2022 - 02/2004
6	Precision Medicine 01/2022 - 07/2016